At ₹49 per tablet, Lupin launches Covihalt for covid treatment

www.livemint.com
2 min read
fairly difficult
Covihalt is available as 200 mg tablets in the form of a strip of 10 tablets for treatment of mild to moderate COVID-19: Lupin
Pharma major Lupin Limited today announced the launch of its Favipiravir in India under the brand name Covihalt for the treatment of mild to moderate COVID-19. It is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs. 49 per tablet, Lupin said.

Favipiravir has received authorization from the Drug Controller General of India (DCGI) for emergency use. Favipiravir was originally developed by Japan's Fujifilm Holdings Corp under the brand name Avigan for treating influenza.

Commenting on the development, Rajeev Sibal, President - India Region Formulations (IRF), at Lupin, said, "We believe that we can leverage our expertise in managing widespread community diseases like TB to…
Surajit Dasgupta
Read full article